Agenda


Thursday, Feb. 10, 2022

5:00 p.m. – 7:00 p.m. – Registration – Salon II Foyer

Friday, Feb. 11, 2022

7:00 a.m. – 7:55 a.m. – Registration, Breakfast and Exhibits

Session I: Breast Cancer Risk Factors
Moderator: Freya Schnabel, MD

7:55 a.m. – 8:00 a.m. Introductory Remarks
Shahla Masood, MD

8:00 a.m. – 8:30 a.m. Precision Medicine and Cancer: A View from the Intersection of Promise and Reality
Alexander S. Parker, MS, PhD

8:30 a.m. – 9:00 a.m. Genetic Susceptibility to Breast Cancer: Beyond BRCA1 and 2
Freya Schnabel, MD

9:00 a.m. – 9:30 a.m. High Risk Breast Lesions: Morphology and Follow-up Management
Shahla Masood, MD

9:30 a.m. – 10:00 a.m. Beyond Breast Density: Risk Assessment in the Breast Imaging Clinic
Emily F. Conant, MD

10:00 a.m. – 10:30 a.m. BREAK and EXHIBITS

10:30 a.m. – 11:00 a.m. An Update on Breast Ultrasound
Gary J. Whitman, MD

11:00 a.m. – 11:30 a.m. Abbreviated Breast MRI for Supplemental Screening
Emily F. Conant, MD

11:30 a.m. – 12:00 p.m. Panel Discussion:
Emily F. Conant, MD; Shahla Masood, MD; Alexander S. Parker, MS, PhD; Freya Schnabel, MD and Gary J. Whitman, MD

12:00 p.m. – 1:00 p.m. LUNCH AND EXHIBITS

Session II: Advances in Breast Cancer Therapy
Moderator: Lisa Spiguel, MD

1:00 p.m. – 1:30 p.m. Axillary Management
Armando E. Giuliano, MD

1:30 p.m. – 2:00 p.m. Management of Node Positive Breast Cancer Patients after Neoadjuvant Chemotherapy
Abigail S. Caudle, MD

2:00 p.m. – 2:30 p.m. Radiation after Neoadjuvant Chemotherapy
Mylin Torres, MD

2:30 p.m. – 3:00 p.m. BREAK and EXHIBITS

3:00 p.m. – 3:30 p.m. Methods for Breast Localization
Abigail S. Caudle, MD

3:30 p.m. – 4:00 p.m. Decision Making in Prophylactic Mastectomy
Lisa Spiguel, MD

4:00 p.m. – 4:30 p.m. Lumpectomy Margins Assessment
Armando E. Giuliano, MD

4:30 p.m. – 5:00 p.m. Panel Discussion:
Abigail S. Caudle, MD; Armando E. Giuliano, MD; Lisa Spiguel, MD and Mylin Torres, MD

Saturday, Feb. 12, 2022

7:00 a.m. – 8:00 a.m. – Registration, Breakfast and Exhibits

Session III: Advances in Breast Cancer Therapy
Moderator: Debu Tripathy, MD

8:00 a.m. – 8:15 a.m. Introduction Keynote Speaker
Shahla Masood, MD

8:15 a.m. – 9:00 a.m. Keynote Lecture – Genomically-Informed Breast Cancer Therapy
Debu Tripathy, MD

9:00 a.m. – 9:30 a.m. How to Select Genomic Assays Rationally?
Jorge S. Reis-Filho, MD

9:30 a.m. – 10:00 a.m. Diversity in Breast Cancer Morphology and Biology: The Landscape of Triple Negative Breast Cancer
Shahla Masood, MD

10:00 a.m. – 10:30 a.m. BREAK AND EXHIBITS


10:30 a.m. – 11:00 a.m. An Update on Immunotherapy
Debu Tripathy, MD

11:00 a.m. – 11:30 a.m. An Update on Her2/neu Therapy
Charles L. Shapiro, MD

11:30 a.m. – 12:00 p.m. Panel Discussion:
Shahla Masood, MD; Jorge S Reis-Filho, MD; Charles L. Shapiro, MD and Debu Tripathy, MD

12:00 p.m. – 1:30 p.m. LUNCH AND EXHIBITS

12:30 p.m. – 1:00 p.m. LUNCH PRESENTATION – Liquid Biopsy: Is there a Role in Breast Cancer Management?
Anthony M. Magliocco, MD (Not eligible for CME credit)

Session IV: Breast Cancer Therapy
Moderator: Charles L. Shapiro, MD

1:30 p.m. – 2:00 p.m. Accelerated Partial Breast Irradiation
Mylin Torres, MD

2:00 p.m. – 2:30 p.m. Hypofractionation
Julie A. Bradley, MD

2:30 p.m. – 3:00 p.m. The Status of Oligometastasis Ablations in Breast Cancer
Paul Okunieff, MD

3:00 p.m. – 3:30 p.m. BREAK and EXHIBITS

3:30 p.m. – 4:00 p.m. Breast Reconstruction after Partial Mastectomy with Oncoplasty
Kent K. Higdon, MD

4:00 p.m. – 4:30 p.m. The Adjuvant Use of Bisphoshonates as Anti-Cancer Therapy
Charles L. Shapiro, MD

4:30 p.m. – 5:00 p.m. Panel Discussion:
Julie A. Bradley, MD; Ken K. Higdon, MD; Paul Okunieff, MD; Charles L. Shapiro, MD and Mylin Torres, MD

Sunday, Feb. 13, 2022

7:00 a.m. – 8:00 a.m. – Registration, Breakfast and Exhibits

Session V: Contemporary Issues in Breast Cancer
Moderator: Kent K. Higdon, MD

8:00 a.m. – 8:30 a.m. Fertility Preservation for Cancer Survivors
Heather Macdonald, MD

8:30 a.m. – 9:00 a.m. Breast Cancer Related Lymphedema, the Importance of a Lymphedema Surveillance Program
Lisa Spiguel, MD

9:00 a.m. – 9:30 a.m. Menopause Management in Breast Cancer Survivors
Heather Macdonald, MD

9:30 a.m. – 10:00 a.m. Breast Implant Associated Anaplastic Large Cell Lymphoma
Kent K. Higdon, MD

10:00 a.m. – 10:30 a.m. Panel Discussion:
Kent K. Higdon, MD; Heather Macdonald, MD; and Lisa Spiguel, MD

10:30 a.m. – 11:00 a.m. Closing Remarks
Shahla Masood, MD